Spencer v. Laboratory Corporation of America Holdings

District Court, E.D. New York·Decided November 30, 2020·No. 2:19-cv-04927·Unknown

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK For Online Publication Only ----------------------------------------------------------------X JAHQUAN SPENCER,

Plaintiff,

-against- MEMORANDUM AND ORDER 19-CV-04927 (JMA) (ARL) LABORATORY CORPORATION OF AMERICA HOLDINGS, PSYCHEMEDICS CORPORATION,

Defendants. FILED CLERK ----------------------------------------------------------------X

APPEARANCES: 11/30/2020 3:08 pm

U.S. DISTRICT COURT Jahquan Spencer EASTERN DISTRICT OF NEW YORK Pro se Plaintiff LONG ISLAND OFFICE

Daniel M. Bernstein Jinkal Pujara Michael K. Clarkson Ogletree, Deakins, Nash, Smoak & Stewart, P.C. 599 Lexington Avenue 17th Floor New York, New York 10022

Sandra Kahn Ogletree, Deakins, Nash, Smoak & Stewart, P.C. One Boston Place Suite 3500 Boston, Massachusetts 02108 Attorneys for Defendant Psychemedics Corporation

Robert I. Steiner Jaclyn Marie Metzinger Kelley, Drye & Warren 101 Park Avenue New York, New York 10178 Attorneys for Defendant Laboratory Corporation of America Holdings AZRACK, United States District Judge: Plaintiff, Jahquan Spencer (“plaintiff”), acting pro se, commenced this diversity action on August 28, 2019 against Laboratory Corporation of America Holdings (“LabCorp”) and Psychemedics Corporation (“Psychemedics” or the “defendant”) (together, the “defendants”). Plaintiff’s amended complaint alleges state law claims for fraud, intentional infliction of emotional

distress, and negligent infliction of emotional distress. (Amended Complaint (“AC”), ECF No. 24.) Before the Court is defendant Psychemedics’s motion to dismiss the amended complaint pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure. (Def.’s Mot. to Dismiss, ECF No. 25.) For the reasons discussed below, the Court grants defendant’s motion and dismisses plaintiff’s amended complaint as against Psychemedics. I. BACKGROUND A. Factual Background The following facts are taken from the amended complaint and the record before the Court, including exhibits which are attached or integral to the amended complaint. See Sira v. Morton, 380 F.3d 57, 67 (2d Cir. 2004). Between approximately November 2017 and July 2019, plaintiff was involved in an

ongoing child abuse proceeding in Suffolk County Family Court (“Family Court”). (AC ¶ 12.) The minor children of plaintiff and his girlfriend, Bernadine Cooley (“Cooley”) were removed from their care due to allegations of child abuse and neglect on the part of both parents. (Id. ¶ 13.) In or about November 2017, plaintiff and his girlfriend were required to complete court-ordered hair follicle and urine drug tests. (Id. ¶ 14.) The urine tests for plaintiff and his girlfriend came back negative, but both hair follicle tests were positive for cocaine. (Id.) Plaintiff claims that neither of them have ever used any drugs and believes that EAC Network, TASC, (“EAC”), a non- profit organization that provides treatment services to individuals who have substance abuse problems, was tampering with collections or falsifying hair follicle results at Family Court.1 (Id. ¶ ¶ 14, 24-25.) On or about August 17, 2018, non-party, Cooley requested a self-paid hair follicle test from Rabu Diagnostic (“Rabu”). (Id. ¶ 26.) Rabu collected Cooley’s hair specimen and shipped it to Omega Laboratories Inc. (“Omega”). (Id.) Cooley tested negative for all substances and allegedly

used this negative test result to dispute EAC’s prior positive test result. (Id.) On or about August 28, 2018, plaintiff went to Rabu and requested a self-paid hair follicle test that was to be tested by LabCorp.2 (Id. ¶ 24.) Rabu collected plaintiff’s hair follicle and placed the specimen in a LabCorp specimen pouch and sealed it. (Id. ¶ 27.) Plaintiff was then requested to print his initials on the LabCorp specimen pouch and sign chain of custody forms, which he did. (Id.) Plaintiff was provided with a donor copy of the chain of custody which listed LabCorp’s New Jersey location as the testing site. (Id. ¶ ¶ 27, 28.) On or about September 4, 2018, Rabu emailed plaintiff a copy of LabCorp’s report of his test results which stated that plaintiff was positive for cocaine. (Id. ¶ 29, AC, Ex. 1, ECF No. 24-

3 at 2-3.) Non-defendant, D.R.S., a medical review company, emailed plaintiff a medical review copy of his test results which also indicated that he tested positive for cocaine. (AC ¶ ¶ 17, 29, Ex. 1 at 4-5.) On or about October 18, 2018, plaintiff requested a laboratory copy of the chain of custody form in regard to his positive test result from Rabu. (AC ¶ 30.) That same day, Rabu forwarded plaintiff a copy of the collector chain of custody form. (AC ¶ 30, Ex. 2, ECF No. 24-4, at 2-3.)

1 At one point in his opposition papers, Plaintiff appears to indicate that, on two different occasions, he underwent hair follicle tests in family court and falsely tested positive. (Pl.’s Opp. to Mot. to Dismiss, ECF No. 28, at 15.)

2 The Court notes that plaintiff also had an unrelated pre-employment urine drug test performed by LabCorp on or about August 17, 2018 of which the results were negative. (AC, Ex. 5, ECF No. 24-6, at 7.) Plaintiff alleges that the collector chain of custody form for his specimen is missing signatures in three areas, including: “received at lab,” “primary specimen bottle seal intact,” and “specimen bottle released to.” (Id.) The chain of custody form contains plaintiff’s signature and states that the specimen bottle was released to “LabCorp Courier,” but it does not state a date or include a signature. (AC, Ex. 2 at 3.)

On or about October 29, 2018, plaintiff went to Rabu to file a complaint because he believed that his test results were falsified or that his specimen had been tampered with. (AC ¶ 31.) Rabu instructed plaintiff to request a litigation package from LabCorp. (Id.) In or about November 2018, plaintiff requested and received a litigation package from LabCorp containing documents pertaining to the laboratory results report plaintiff had received from Rabu in September. (Id. ¶¶ 32, 33.) Plaintiff claims that it was not until he received this litigation package that he discovered that his specimen had not actually been tested by LabCorp, but instead was tested by Psychemedics. (Id. ¶ 33.) He also alleges that the laboratory result copy that Rabu had previously emailed to plaintiff was not included in the litigation package and that the chain of

Free access — add to your briefcase to read the full text and ask questions with AI

Spencer v. Laboratory Corporation of America Holdings, (E.D.N.Y. 2020).

Spencer v. Laboratory Corporation of America Holdings (Spencer v. Laboratory Corporation of America Holdings) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Coppedge v. United States
369 U.S. 438 (Supreme Court, 1962)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Stuto v. Fleishman
164 F.3d 820 (Second Circuit, 1999)
Manning v. Utilities Mutual Insurance Co.
254 F.3d 387 (Second Circuit, 2001)
Premium Mortgage Corp. v. Equifax, Inc.
583 F.3d 103 (Second Circuit, 2009)
Shomo v. City of New York
579 F.3d 176 (Second Circuit, 2009)
Harris v. Mills
572 F.3d 66 (Second Circuit, 2009)
Lama Holding Co. v. Smith Barney Inc.
668 N.E.2d 1370 (New York Court of Appeals, 1996)
Abercrombie v. Andrew College
438 F. Supp. 2d 243 (S.D. New York, 2006)
Matter of Ferrara (Catherwood)
176 N.E.2d 43 (New York Court of Appeals, 1961)
Taggart v. Costabile
131 A.D.3d 243 (Appellate Division of the Supreme Court of New York, 2015)